UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 2030, 2010

MIDDLEBROOK PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)


Delaware	000-50414	52-2208264

(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

9 Village Circle, Suite 545, Westlake, Texas		76262
7 Village Circle, Suite 100, Westlake, Texas		76262
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (817) 837-1200

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7 1.0103. ~~Regulation~~Bankruptcy FDor ~~Disclosure~~Receivership.

OnAs ~~December~~previously disclosed, on April 2030, 2010, MiddleBrook Pharmaceuticals, Inc. (“MiddleBrook” or the “Company”) filed ~~its~~a ~~unaudited monthly~~voluntary ~~operating~~petition ~~report~~for ~~(the~~bankruptcy ~~“Monthly~~protection ~~Operating~~under ~~Report”)~~Chapter 11 ~~for~~of the United ~~period~~States ~~November 1,~~Bankruptcy ~~2010~~Code ~~through November 30,~~(the ~~2010~~“Bankruptcy ~~with~~Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), case number 10-11485. ~~A copy of the Monthly Operating Report is attached to~~ ~~this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.~~

~~The~~On ~~Monthly~~November 4, ~~Operating~~2010, ~~Report~~MiddleBrook isfiled ~~limited~~the inDebtor’s ~~scope,~~Plan ~~covers~~of aLiquidation ~~limited time period~~ and ~~has~~the ~~been~~Disclosure ~~prepared~~Statement ~~solely~~ for the ~~purpose~~Debtor’s ofPlan ~~complying with reporting requirements~~ of ~~the~~Liquidation ~~Bankruptcy Court and the United States Bankruptcy Code, 11 U.S.C. §§ 101-1532~~ (the “~~Bankruptcy~~Disclosure ~~Code”~~Statement’). ~~The financial~~with ~~information contained in~~ the ~~Monthly Operating Report is preliminary and unaudited and~~Bankruptcy ~~does~~Court. ~~not~~On ~~purport to show the Company’s financial statements in accordance with generally accepted accounting principles (“GAAP”) and~~December 30, ~~therefore~~2010, ~~may~~MiddleBrook ~~exclude~~filed ~~items required by GAAP. The Monthly Operating Report also does not include footnotes that would ordinarily be contained in~~ the ~~financial~~ ~~statements in the Company~~Debtor’s ~~quarterly~~Modified ~~and~~Plan ~~annual reports filed pursuant to the Securities Exchange Act~~ of ~~1934,~~Liquidation ~~as amended~~ (the “~~Exchange~~Modified ~~Act~~Plan”). ~~The~~with ~~Monthly Operating Report contains information for periods that may be shorter or otherwise different from those contained in reports required pursuant to~~ the ~~Exchange~~Bankruptcy ~~Act~~Court. ~~The~~An ~~financial~~order ~~information~~confirming ~~has~~the ~~not~~Modified ~~been~~Plan ~~reviewed~~was orentered ~~otherwise verified for accuracy or completeness~~ by the ~~Company’s~~Bankruptcy ~~independent~~Court ~~registered~~on ~~public~~December 30, ~~accountants~~2010, and ~~there can be no assurance that~~ the ~~Monthly~~Modified ~~Operating~~Plan ~~Report~~became iseffective ~~complete. The Company cautions readers not to place undue reliance~~ on ~~the Monthly Operating Report~~January 3, ~~which may be subject to~~ ~~revision.~~2011 ~~The Monthly Operating Report is in~~ (the ~~format~~“Effective ~~required by the Bankruptcy Court and the Bankruptcy Code and should not be used for investment purposes~~Date”). ~~The information in the Monthly~~ ~~Operating Report should not be viewed as indicative of future results.~~

The ~~information~~Modified ~~furnished~~Plan ~~pursuant~~provides tofor ~~Item 7.01~~the ~~and~~resolution ~~Exhibit 99.1~~ of ~~this~~outstanding ~~Current~~claims ~~Report~~against ~~on Form~~and ~~8-K~~interests ~~shall~~in the ~~not~~Company. beAs ~~deemed~~provided toin bethe ~~“filed”~~Modified ~~for~~Plan, ~~the~~allowed ~~purposes~~administrative ofexpenses, ~~Section 18~~allowed ofpriority tax ~~the~~and ~~Exchange~~priority ~~Act~~non-tax claims, ~~or otherwise~~and ~~subject~~allowed togeneral ~~the~~unsecured ~~liabilities~~claims ofwill ~~that~~be ~~section.~~paid ~~The information~~ in ~~Item 7.01~~full offrom ~~this Current~~the ~~Report~~bankruptcy ~~shall~~estate ~~not~~as beshortly ~~incorporated~~after bythe ~~reference~~Effective ~~into~~Date ~~any~~as ~~filing~~practicable ~~under~~or the ~~Securities~~date ~~Act~~on ofwhich ~~1933~~such claims become allowed, as ~~amended,~~ ordefined in the ~~Exchange~~Modified ~~Act~~Plan. The remaining cash in the bankruptcy estate, ~~whether~~if ~~made~~any, ~~before~~will orbe ~~after~~distributed to the ~~date~~holders of ~~this~~allowed ~~Current~~interests ~~Report, regardless~~on ofa ~~any~~pro ~~general~~rata ~~incorporation~~basis, ~~language~~as provided in the ~~filing~~Modified Plan.

At January 6, 2011, the Company had one share of common stock issued and outstanding. Under the terms of the Modified Plan, all shares of the Company’s common stock were cancelled on the Effective Date and one share was issued to Ronald L. Glass, the plan administrator. No shares of common stock will be issued with respect to claims or interests under the Modified Plan.

The assets and liabilities of the Company as of November 30, 2010 are set forth in the unaudited Monthly Operating Report for the month ended November 30, 2010 (the “Monthly Operating Report”), filed by the Company with the Bankruptcy Court and the Securities Exchange Commission on Form 8-K on December 20, 2010.

The foregoing description of the Plan does not purport to be complete and is qualified in its entirety by reference to the copy of the Modified Plan which is filed as Exhibit 2.1 to this report.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are ~~furnished~~filed with this Current Report on Form 8-K:

Exhibit
Number		Description
	99.1	Monthly Operating Report for the Period from November 1, 2010 to November 30, 2010
	2.1	Debtor’s Modified Plan of Liquidation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MIDDLEBROOK PHARMACEUTICALS, INC.
Date: December 20, 2010	By:	/s/ Brad Cole
Date: January 6, 2011	By:	/s/ Ronald L. Glass
		Brad Cole
		Ronald L. Glass
		Senior Vice President, General Counsel and Secretary
		Plan Administrator

EXHIBIT INDEX

Exhibit
Number		Description
	99.1	Monthly Operating Report for the Period from November 1, 2010 to November 30, 2010
	2.1	Debtor’s Modified Plan of Liquidation

Filing Compare · MiddleBrook Pharmaceuticals, Inc.